title: [Osteoporosis].
authors.affiliation: Osteologische Ambulanz, Medizinische Klinik III, Klinikum der Universität München-Grosshadern, 81366 München.
authors.forename: R
authors.initials: R
authors.lastname: Bartl
mesh_terms: D019386:Alendronate / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D004359:Drug Therapy, Combination; D015914:Estrogen Replacement Therapy; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000209:etiology; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000068296:Risedronic Acid
chemical_list: D020849:Raloxifene Hydrochloride; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate